Takeda (Thailand) Ltd.
R&D Pharmaceuticals and vaccine
- Peter Streibl, General Manager
- Jacek Slomczynski, Finance Head
- Mayuree Lertwatanakulsiri, Human Resources Head
- Praphaphan Phrommart, Market Access, Public Affairs Head
- Thitima Lecksiwilai, Communication Lead
57 Park Ventures Ecoplex Building, 15th Floor, Wireless Road, Lumpini, Patumwan, Bangkok 10330
+66 2697 9300
+66 2697 9398-9
We commit to bringing innovative therapies to Thai patients in five core areas: Gastroenterology (GI), Oncology, Rare Diseases, Plasma Derived Therapies and Vaccines
Contact information for member only.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. We are focusing on developing novel medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving the quality of life for patients and to working with our partners in health care in approximately 80 countries.
Established in 1969, Takeda Thailand is the third longest running business within the company’s global footprint. We have been operating in Thailand for more than 50 years with approximately 200 employees. We are committed to delivering better health for people and a brighter future for the world. Aligned with Takeda’s global strategy.